Modulation of the Random Migration of Human Platelets
Open Access
- 1 November 1974
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 54 (5) , 1100-1106
- https://doi.org/10.1172/jci107854
Abstract
Random migration of human platelets has been recognized as a parameter of platelet function which can be assessed in a reproducible manner by modification of the Boyden micropore filter technique for evaluating this function in other cells (Boyden, S. 1962. J. Exp. Med. 115: 453-466). Because platelets are extremely susceptible to aggregation, the conditions for collecting and isolating platelets and the migration buffer (Ca++ and Mg++-free phosphate buffered saline, pH 6.8, with glucose and gelatin) were selected to minimize such a possibility. The random movement of platelets into the micropore filter was maximal at 30-37°C and was contingent upon the metabolic integrity of the cell; thus, it can be attributed to active spontaneous migration. While the initiating and enhancing effects of epinephrine on the platelet aggregation-release reaction are mediated by an α-adrenergic receptor, the inhibition of random migration involved a β-receptor. Equimolar propranolol but not phentolamine prevented epinephrine inhibition of random migration, and isoproterenol had activity comparable to epinephrine while phenylephrine was inactive. The capacity of the cholinomimetic agent, carbachol, to increase platelet migration is reminiscent of the recent findings in several cell systems in which β-adrenergic and cholinergic stimuli have opposite effects. The prostaglandins E1 and E2 augmented spontaneous migration in contrast to their well established inhibitory action on platelet aggregation at the concentrations employed. The suppression by indomethacin of prostaglandin enhancement and of spontaneous migration implies a requirement for the prostaglandin biosynthetic pathway during the migration process. Thus, the spontaneous migration of human platelets, an additional parameter of platelet function for in vitro investigations, disclosed not only a β-adrenergic receptor for epinephrine, but also a capacity for cholinergic augmentation and an apparent requirement for prostaglandin biosynthesis.Keywords
This publication has 17 references indexed in Scilit:
- Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.Journal of Clinical Investigation, 1974
- THE MODULATING INFLUENCE OF CYCLIC NUCLEOTIDES UPON LYMPHOCYTE-MEDIATED CYTOTOXICITYThe Journal of Experimental Medicine, 1973
- Enzyme Release from Polymorphonuclear Leukocyte Lysosomes: Regulation by Autonomic Drugs and Cyclic NucleotidesScience, 1973
- IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNGThe Journal of Experimental Medicine, 1972
- Effect of 6–Aminonicotinamide on Insulin Release and C–14 Glucose Oxidation by Isolated Pancreatic Rat Islets: Difference between Glucose, Tolbutamide and Aminophylline*Endocrinology, 1972
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.1970
- Relationship between chemical structure and plateletaggregation activity of prostaglandinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969
- β-Adrenergic receptors in human plateletsJournal of Atherosclerosis Research, 1969
- Effects of adrenaline on human blood plateletsThe Journal of Physiology, 1967